Abstract
Poliomyelitis (polio) is a highly infectious intestinal disease caused by the poliovirus. Poliovirus is transmitted by person-to-person spread mainly through the fecal–oral route, or, less frequently, by contaminated water or food. Humans are the only known reservoir of poliovirus, which is transmitted most frequently by persons with inapparent infections. Initial symptoms of polio include fever, fatigue, headache, vomiting, stiffness in the neck, and pain in the limbs. In a small proportion of cases (1 in 200 infections), poliovirus causes paralysis, which is often permanent. Instead of a cure for polio, it can only be prevented. The Polio vaccine, given multiple times, can protect a child for life.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
WHO. Poliomyelitis. https://www.who.int/en/news-room/fact-sheets/detail/poliomyelitis. 2019.
Greene SA, Ahmed J, Datta SD, et al. Progress toward polio eradication—worldwide, January 2017–March 2019. MMWR. 2019;68(20):458–62.
WHO. Poliomyelitis disease outbreak news. https://www.who.int/csr/don/archive/disease/poliomyelitis/en/. 2019.
WHO. Immunization, Vaccines and Biologicals. https://www.who.int/immunization/monitoring_surveillance/data/en/. 2019.
Global Polio Eradication Initiative. Key At-Risk Countries. http://polioeradication.org/where-we-work/key-at-risk-countries/. 2019.
National Health and Family Planning Commission. PRC, Poliomyelitis Diagnosis (WS 294-2016). 2016.
Luo HM, Zhang Y, Wang XQ, et al. Identification and control of a poliomyelitis outbreak in Xinjiang, China. N Engl J Med. 2013;369(21):1981–90.
Wenzhou Y, Wushouer F, Haibo W, et al. Experience and lessons learned from the investigation of and response to imported wild poliovirus causing local transmission in Xinjiang Uygur Autonomous Region in 2011. Chin J Vac Immuniz. 2013;19(04):361–4.
WHO. Standard operating procedures; Responding to a poliovirus event or outbreak version, vol. 3. Geneva: World Health Organization; 2018.
WHO. Measles. https://www.who.int/immunization/diseases/measles/en/. 2019.
WHO. Measles—Global situation. https://www.who.int/csr/don/26-november-2019-measles-global_situation/en/. 2019.
Chinese Center for Disease Control and Prevention. Knowledge of measles prevention and control. Aust Health Rev. 2017;2:63.
WHO. WHO recommended strategies for the prevention and control of communicable diseases. Geneva: WHO Press; 2001.
National Health Commission. PRC, Diagnosis of Epidemic Cerebrospinal Meningitis (WS 295-2019). 2019.
GBD. 2015 Disease and Injury Incidence and Prevalence Collaborators. Prevalence, Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1545–602.
Epidemic meningitis control in countries of the. African meningitis belt, 2018. Wkly Epidemiol Rec. 2019;94(14/15):169–88.
Yoshikawa H, Ebihara K, Tanaka Y, et al. Efficacy of quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine (GARDASIL) in Japanese women aged 18-26 years. Cancer Sci. 2013;104(4):465–72.
Ministry of Health, PRC. National Program for Epidemic Cerebrospinal Meningitis Prevention and Control (CDC [2006] No. 32). 2006.
Greenwood B. Manson lecture. Meningococcal meningitis in Africa. Trans R Soc Trop Med Hyg. 1999;93(4):341–53.
Yixing L, Junhong L, Zundong Y, et al. Surveillance and control of epidemic Japanese encephalitis. Chin J Plan Immuniz. 2006;6:527–32.
Fischer M, Lindsey N, Staples JE, et al. Japanese encephalitis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2010;59(RR-1):1–27.
Instructions for the Prevention and Control of. Epidemic Japanese Encephalitis. Chin J Plan Immuniz. 2004;4:63–4.
Guoqiang W. Disease prevention and control in China 1955–2015. Beijing: China Population Publishing House; 2015.
Centers for Disease Control and Prevention. Yellow book 2020: health information for international travel. New York: Oxford University Press; 2017.
WHO. Hepatitis A. https://www.who.int/immunization/diseases/hepatitisA/en/. 2019.
Epidemiological update: hepatitis A outbreak in the EU/EEA mostly affecting men who have sex with men. https://www.ecdc.europa.eu/en/news-events/epidemiological-update-hepatitis-outbreak-eueea-mostly-affecting-men-who-have-sex-men-0. 2017.
Jacobsen KH, Wiersma ST. Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. Vaccine. 2010;28(41):6653–7.
Fiore AE, Wasley A, Bell BP, et al. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2006;55(Rr-7):1–23.
Collier MG, Khudyakov YE, Selvage D, et al. Outbreak of hepatitis A in the USA associated with frozen pomegranate arils imported from Turkey: an epidemiological case study. Lancet Infect Dis. 2014;14(10):976–81.
State of Hawaii, Department of Health. Hepatitis A Outbreak 2016. http://health.hawaii.gov/docd/hepatitis-a-outbreak-2016/. 2016.
CDC. Outbreak of hepatitis A in Hawaii linked to raw scallops. https://www.cdc.gov/hepatitis/outbreaks/2016/hav-hawaii.htm. 2016.
Foster M, Ramachandran S, Myatt K, et al. Hepatitis A virus outbreaks associated with drug use and homelessness—California, Kentucky, Michigan, and Utah, 2017. MMWR. 2018;67(43):1208–10.
Latash J, Dorsinville M, Del Rosso P, et al. Notes from the field: increase in reported hepatitis A infections among men who have sex with men—New York City, January–August 2017. MMWR. 2017;66(37):999–1000.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Su, Q., Ning, G., Luo, H. (2021). Risk Assessment and Control on Vaccine-Preventable Diseases. In: Yang, W. (eds) Prevention and Control of Infectious Diseases in BRI Countries. Springer, Singapore. https://doi.org/10.1007/978-981-33-6958-0_4
Download citation
DOI: https://doi.org/10.1007/978-981-33-6958-0_4
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-33-6957-3
Online ISBN: 978-981-33-6958-0
eBook Packages: MedicineMedicine (R0)